Griffin Asset Management Inc. bought a new position in shares of Aurora Cannabis Inc (NYSE:ACB) during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund bought 13,316 shares of the company’s stock, valued at approximately $128,000.
NYSE ACB traded up $0.44 on Friday, hitting $6.38. 32,314,261 shares of the company’s stock were exchanged, compared to its average volume of 14,832,275. The stock has a market capitalization of $5.44 billion and a price-to-earnings ratio of 28.68. The company has a current ratio of 6.54, a quick ratio of 5.68 and a debt-to-equity ratio of 0.07. Aurora Cannabis Inc has a fifty-two week low of $4.05 and a fifty-two week high of $12.52.
Aurora Cannabis (NYSE:ACB) last released its quarterly earnings results on Monday, November 12th. The company reported $0.09 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.13. The business had revenue of $22.71 million for the quarter. Aurora Cannabis had a return on equity of 8.57% and a net margin of 224.33%.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by PressOracle and is the property of of PressOracle. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://pressoracle.com/news/2019/01/11/13316-shares-in-aurora-cannabis-inc-acb-purchased-by-griffin-asset-management-inc.html.About Aurora Cannabis
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Read More: What is Depreciation?
Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.